(NYSE: CHE) Chemed's forecast annual revenue growth rate of 6.56% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.06%.
Chemed's revenue in 2026 is $2,540,548,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $36,092,288,776, with the lowest CHE revenue forecast at $34,937,441,728, and the highest CHE revenue forecast at $37,592,262,528. On average, 5 Wall Street analysts forecast CHE's revenue for 2027 to be $38,335,612,352, with the lowest CHE revenue forecast at $36,729,445,768, and the highest CHE revenue forecast at $40,300,179,744.
In 2028, CHE is forecast to generate $40,419,646,680 in revenue, with the lowest revenue forecast at $39,211,703,216 and the highest revenue forecast at $42,012,539,160.